By employing several steps, gathering, analysing and recording of market data has been carried out in this circulating tumor cells (CTC) liquid biopsy market. To formulate this report, systematic, objective and exhaustive study of the facts related to any subject in the field of marketing have been performed. Not to mention, various purposes or objectives of market research are kept in mind...
Liquid biopsy is a non-invasive medical procedure that holds the ability to detect the presence of molecular cancer biomarkers in biological fluids. The report includes market estimation for tests/ services, instruments, and kits and consumables used for liquid biopsies of different oncology and non-oncology disorders.
The global liquid biopsy market was estimated to...
The growing incidence of cancer coupled with the increased popularity of minimally invasive medical treatment is facilitating the expansion of the liquid biopsy market. The burgeoning cancer cases can be attributed to numerous factors such as rise in number of cigarette smokers, and the prevalence of infectious diseases including Hepatitis B and C. Liquid biopsy has emerged as preferred...
The Liquid Biopsy Market in 2023 is US$ 5.1 billion, and is expected to reach US$ 19.84 billion by 2031 at a CAGR of 18.52%.
The Surging Surge of the Liquid Biopsy Market in Health Technology
The healthcare sector is undergoing a profound transformation, driven by technologies that promise to reshape patient care paradigms. One such technological marvel is the liquid biopsy—a...
To research, analyze and study the global sales, value, status and forecast (2018 - 2025) is one of the major objectives of the Circulating Tumor Cells (CTC) Liquid Biopsy market report. This global market research report highlights the market drivers and market restraints which are derived from the well-established SWOT analysis. What is more, Circulating Tumor Cells (CTC) Liquid...